These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3325714)

  • 1. The MOPC-315 tumor as a model for the immunomodulatory effects of cyclophosphamide.
    Mokyr MB
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):579-88. PubMed ID: 3325714
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy.
    Dray S; Mokyr MB
    Med Oncol Tumor Pharmacother; 1989; 6(1):77-85. PubMed ID: 2657252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined therapy of experimental tumors with the vaccinal strain of Venezulean encephalomyelitis virus].
    Urazova LN; Gromova AI
    Vopr Onkol; 2001; 47(1):78-80. PubMed ID: 11317543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 6. Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1981 Jun; 41(6):2163-7. PubMed ID: 7016310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
    Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
    Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cyclophosphamide on experimental salivary gland neoplasia.
    Sheehan R; Shklar G
    Cancer Res; 1972 Feb; 32(2):420-5. PubMed ID: 5058196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of preliminary administration of cyclophosphamide and pretransplantation irradiation on the growth of syngeneic tumors in mice].
    Babadzhanov AS; Slavina EG
    Biull Eksp Biol Med; 1983 Jan; 95(1):84-6. PubMed ID: 6338957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic effects of local chemotherapy with an active metabolite of cyclophosphamide.
    Scheper RJ; Limpens J; Tan BT; Valster H; Claessen AM; Claessen ME
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):611-5. PubMed ID: 3325717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.
    Bartik MM; Takesue BY; Mokyr MB
    Cancer Res; 1987 Sep; 47(18):4848-55. PubMed ID: 3497711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of MOPC 104E myeloma in plateau phase.
    Ghanta VK; Hiramoto RN; Davis DW; Hiramoto NS
    Cancer Res; 1980 Jul; 40(7):2372-6. PubMed ID: 7190063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of the experimental immunopharmacology of oxazaphosphorines.
    Fazioli F; Sironi M; Vecchi A; Sozzani S; Spreafico F
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):595-614. PubMed ID: 3325715
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology of cyclophosphamide and metabolites.
    Colvin M; Hilton J
    Cancer Treat Rep; 1981; 65 Suppl 3():89-95. PubMed ID: 7049370
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxazaphosphorine effects in L 5222 rat leukemia.
    Pohl J; Reissmann T; Voegeli R
    Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):589-94. PubMed ID: 3437788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors.
    Tong Y; Song W; Crystal RG
    Cancer Res; 2001 Oct; 61(20):7530-5. PubMed ID: 11606390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by adriamycin.
    Mihich E
    Sci Rep Res Inst Tohoku Univ Med; 1985 Dec; 32(1-4):10-3. PubMed ID: 3915832
    [No Abstract]   [Full Text] [Related]  

  • 18. Ability of cyclophosphamide in the absence of cross-linking activity to exert the immunomodulatory effect required for the cure of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Brundrett RB; Colvin M; Dray S
    Cancer Res; 1986 Jul; 46(7):3313-20. PubMed ID: 3486709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase.
    Loeffler M; Krüger JA; Reisfeld RA
    Cancer Res; 2005 Jun; 65(12):5027-30. PubMed ID: 15958544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease.
    Su YC; Rolph MS; Cooley MA; Sewell WA
    J Allergy Clin Immunol; 2006 Mar; 117(3):635-41. PubMed ID: 16522464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.